相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rapid restoration of natural killer activity following treatment with 2-chlorodeoxyadenosine in 22 patients with hairy-cell leukemia
F. Lauria et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
Monica Else et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness
Davide Rossi et al.
CLINICAL CANCER RESEARCH (2009)
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia:: results from a detailed genetic characterization with long-term follow-up
Thorsten Zenz et al.
BLOOD (2008)
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
Michael Hallek et al.
BLOOD (2008)
High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia
Francesco Forconi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia
Francesco Forconi et al.
HAEMATOLOGICA (2008)
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia
Monica Else et al.
CANCER (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial
Tadeusz Robak et al.
BLOOD (2007)
Complete molecular remission induced by concomitant Cladribine - Rituximab treatment in a case of multi-resistant Hairy Cell Leukemia
Francesco Forconi et al.
LEUKEMIA & LYMPHOMA (2007)
Immunotoxins in the treatment of refractory hairy cell leukemia
Robert J. Kreitman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2006)
Eradication of minimal residual disease in hairy cell leukemia
F Ravandi et al.
BLOOD (2006)
Somatic hypermutation and VH gene usage in hairy cell leukaemia
E Arons et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection
T Soussi et al.
CLINICAL CANCER RESEARCH (2006)
Long remissions in hairy cell leukemia with purine analogs - A report of 219 patients with a median follow-up of 12.5 years
M Else et al.
CANCER (2005)
Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia
M Thorsélius et al.
LEUKEMIA RESEARCH (2005)
Towards the pharmacotherapy of hairy cell leukaemia
F Lauria et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis
V Giudicelli et al.
NUCLEIC ACIDS RESEARCH (2004)
hairy cell leukemia: at the crossroad of somatic mutation and isotype switch
F Forconi et al.
BLOOD (2004)
Chronic lymphocytic leukemia: revelations from the B-cell receptor
FK Stevenson et al.
BLOOD (2004)
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)
B Falini et al.
LANCET (2004)
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma:: correlation with genomic aberrations, clinical characteristics, and outcome
D Kienle et al.
BLOOD (2003)
Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia
J Nieva et al.
BLOOD (2003)
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease
J Orchard et al.
BLOOD (2003)
Extended follow-up of patients with hairy cell leukemia after treatment with cladribine
GR Goodman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia
Y Vasconcelos et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Rituximab in relapsed or refractory hairy cell leukemia
DA Thomas et al.
BLOOD (2003)
Insight into the potential for DNA idiotypic fusion vaccines designed for patients by analysing xenogeneic anti-idiotypic antibody responses
F Forconi et al.
IMMUNOLOGY (2002)
Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing
F Forconi et al.
BLOOD (2001)
The natural history and clinico-pathological features of the variant form of hairy cell leukemia
E Matutes et al.
LEUKEMIA (2001)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
